search-white-svg
Meine Position
i
Ein Tipp vom Eldar Team
Je mehr Sie bestellen, desto grösser Ihr Rabatt
Lieferbar
The Kidney in Heart Failure
Buch
Buch
disk-white-svg
Fachbuch
2012

The Kidney in Heart Failure

ISBN
EAN
978-1-4614-3693-5
9781461436935
Artikel-Nr.
3WEWYR8
Kostenloser Versand
Rabatt
-15.5
%
CHF 264.00
CHF
223.16
Anzahl
1
Maximale
Lieferzeit
20
Arbeitstage
Freitag
20.08.2021
speech-bubble-svg Beschreibung
Chronic Kidney Disease (CKD) is a recognized risk factor for cardiovascular events and death.  The coexistence of CKD and heart failure is increasing in prevalence worldwide and requires a unique and subtle approach to patient management. The Kidney in Heart Failure focuses on the changes that occur in kidney physiology as a function of a failing heart.  This comprehensive resource covers epidemiology, pathophysiology, management of kidney disorders and advances in nephropathy management.  In addition, the latest therapies, common heart failure dilemmas and kidney disease markers are included.  Each chapter is co-authored by a Nephrologist and Cardiologist, offering a unified perspective to these chronic conditions. This indispensible volume provides the reader with the depth-of-knowledge needed for assessing and treating the cardio renal patient.
Inhaltsverzeichnis
Foreword                   Peter A. McCulloughPrefacePart One                     Epidemiology

Chapter 1                    Epidemiology of Chronic Kidney Disease in Heart Failure

                                    Ruth C. Campbell and Ali Ahmed

Chapter 2                    Anemia and Cardiovascular Risk in the Kidney Disease Patients:

                                    What is the best way to achieve and what is the desired hemoglobin?

                                    Tejas V. Patel and Ajay K. Singh

 Part Two                    PathophysiologyChapter 3                    Renal Hemodynamic Changes in Heart Failure

                                    Ivana Lazich and George L. Bakris

Chapter 4                    Changes in Kidney Function Following Heart Failure Treatment:  Focus on RAS                                       Blockade

                                    Mohammed Shakaib and George L. Bakris

Chapter 5                    Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient

                                    Biff F. Palmer

Chapter 6                    B-Type Natriuretic Peptide: Beyond Diagnostic Applications

                                    Ivan D. Hanson and Peter A. McCullough

 

Part Three                 Management of Kidney Associated Clinical Problems

Chapter 7                    Hyperkalemia Risk and Treatment of Heart Failure

                                    Julian Segura and Luis M. Ruilope

Chapter 8                    Management of Heart Failure with Renal Artery Ischaemia

                                    Andrew K. Roy and Patrick Murray

Chapter 9                    Renal Consequences of Prostaglandin Inhibition in Heart Failure

                                    Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir

Chapter 10                  Edema Mechanisms in the Heart Failure Patient and Treatment Options

                                    Domenic A. Sica

Chapter 11                  Ultrafiltration and Heart Failure

                                    Paul Chacko, Donald Kikta Jr., William T. Abraham

 

Part Four                   Advances in Nephropathy Management: Influences on CVD Risk

Chapter 12                  Combination Therapy in Hypertension Treatment

                                    Raymond V. Oliva and George L. Bakris

Chapter 13                  Medication Adherence in Heart Failure

                                    Daniel E. Hilleman and Jennifer A. Campbell

Chapter 14                  New Markers of Vascular Risk

                                    David Davidson and Michael H. Davidson

Chapter 15                  Dietary Paradoxes to Optimize CV Risk Management in CKD

                                    Raghu V. Durvasula and Katherine R. Tuttle

PrefacePart One                     Epidemiology

Chapter 1                    Epidemiology of Chronic Kidney Disease in Heart Failure

                                    Ruth C. Campbell and Ali Ahmed

Chapter 2                    Anemia and Cardiovascular Risk in the Kidney Disease Patients:

                                    What is the best way to achieve and what is the desired hemoglobin?

                                    Tejas V. Patel and Ajay K. Singh

 Part Two                    PathophysiologyChapter 3                    Renal Hemodynamic Changes in Heart Failure

                                    Ivana Lazich and George L. Bakris

Chapter 4                    Changes in Kidney Function Following Heart Failure Treatment:  Focus on RAS                                       Blockade

                                    Mohammed Shakaib and George L. Bakris

Chapter 5                    Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient

                                    Biff F. Palmer

Chapter 6                    B-Type Natriuretic Peptide: Beyond Diagnostic Applications

                                    Ivan D. Hanson and Peter A. McCullough

 

Part Three                 Management of Kidney Associated Clinical Problems

Chapter 7                    Hyperkalemia Risk and Treatment of Heart Failure

                                    Julian Segura and Luis M. Ruilope

Chapter 8                    Management of Heart Failure with Renal Artery Ischaemia

                                    Andrew K. Roy and Patrick Murray

Chapter 9                    Renal Consequences of Prostaglandin Inhibition in Heart Failure

                                    Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir

Chapter 10                  Edema Mechanisms in the Heart Failure Patient and Treatment Options

                                    Domenic A. Sica

Chapter 11                  Ultrafiltration and Heart Failure

                                    Paul Chacko, Donald Kikta Jr., William T. Abraham

 

Part Four                   Advances in Nephropathy Management: Influences on CVD Risk

Chapter 12                  Combination Therapy in Hypertension Treatment

                                    Raymond V. Oliva and George L. Bakris

Chapter 13                  Medication Adherence in Heart Failure

                                    Daniel E. Hilleman and Jennifer A. Campbell

Chapter 14                  New Markers of Vascular Risk

                                    David Davidson and Michael H. Davidson

Chapter 15                  Dietary Paradoxes to Optimize CV Risk Management in CKD

                                    Raghu V. Durvasula and Katherine R. Tuttle

                                    Ivana Lazich and George L. Bakris

Chapter 4                    Changes in Kidney Function Following Heart Failure Treatment:  Focus on RAS                                       Blockade

                                    Mohammed Shakaib and George L. Bakris

Chapter 5                    Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient

                                    Biff F. Palmer

Chapter 6                    B-Type Natriuretic Peptide: Beyond Diagnostic Applications

                                    Ivan D. Hanson and Peter A. McCullough

 

Part Three                 Management of Kidney Associated Clinical Problems

Chapter 7                    Hyperkalemia Risk and Treatment of Heart Failure

                                    Julian Segura and Luis M. Ruilope

Chapter 8                    Management of Heart Failure with Renal Artery Ischaemia

                                    Andrew K. Roy and Patrick Murray

Chapter 9                    Renal Consequences of Prostaglandin Inhibition in Heart Failure

                                    Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir

Chapter 10                  Edema Mechanisms in the Heart Failure Patient and Treatment Options

                                    Domenic A. Sica

Chapter 11                  Ultrafiltration and Heart Failure

                                    Paul Chacko, Donald Kikta Jr., William T. Abraham

 

Part Four                   Advances in Nephropathy Management: Influences on CVD Risk

Chapter 12                  Combination Therapy in Hypertension Treatment

                                    Raymond V. Oliva and George L. Bakris

Chapter 13                  Medication Adherence in Heart Failure

                                    Daniel E. Hilleman and Jennifer A. Campbell

Chapter 14                  New Markers of Vascular Risk

                                    David Davidson and Michael H. Davidson

Chapter 15                  Dietary Paradoxes to Optimize CV Risk Management in CKD

                                    Raghu V. Durvasula and Katherine R. Tuttle

                                    Mohammed Shakaib and George L. Bakris

Chapter 5                    Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient

                                    Biff F. Palmer

Chapter 6                    B-Type Natriuretic Peptide: Beyond Diagnostic Applications

                                    Ivan D. Hanson and Peter A. McCullough

 

Part Three                 Management of Kidney Associated Clinical Problems

Chapter 7                    Hyperkalemia Risk and Treatment of Heart Failure

                                    Julian Segura and Luis M. Ruilope

Chapter 8                    Management of Heart Failure with Renal Artery Ischaemia

                                    Andrew K. Roy and Patrick Murray

Chapter 9                    Renal Consequences of Prostaglandin Inhibition in Heart Failure

                                    Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir

Chapter 10                  Edema Mechanisms in the Heart Failure Patient and Treatment Options

                                    Domenic A. Sica

Chapter 11                  Ultrafiltration and Heart Failure

                                    Paul Chacko, Donald Kikta Jr., William T. Abraham

 

Part Four                   Advances in Nephropathy Management: Influences on CVD Risk

Chapter 12                  Combination Therapy in Hypertension Treatment

                                    Raymond V. Oliva and George L. Bakris

Chapter 13                  Medication Adherence in Heart Failure

                                    Daniel E. Hilleman and Jennifer A. Campbell

Chapter 14                  New Markers of Vascular Risk

                                    David Davidson and Michael H. Davidson

Chapter 15                  Dietary Paradoxes to Optimize CV Risk Management in CKD

                                    Raghu V. Durvasula and Katherine R. Tuttle

feather-svg
Herausgeber/-in
Herausgegeben von
Autorenporträt

Dr. Bakris is currently Professor of Medicine and Director of the Hypertension Center at the University of Chicago Pritzker School of Medicine. Dr. Bakris has published over 600 articles and book chapters in the areas of diabetic kidney disease, hypertension and progression of nephropathy. He is the Editor or Co-Editor of eight books, in the areas of Kidney Disease Progression and Diabetes. Additionally, he is the Associate Editor of the International Textbook of Cardiology. He chaired the first National Kidney Foundation Consensus report on blood pressure and impact on renal disease progression (2000). He has also served on many national guideline committees including: JNC VI and 7 writing committees, the JNC 7 executive committee, the American Diabetes Association Clinical Practice Guideline Committee. Dr. Bakris is also the past-president of the American College of Clinical Pharmacology and the current President of the American Society of Hypertension (ASH) (2010-2012). He is the current Editor of American Journal of Nephrology and Hypertension, Section Editor of Up-to-Date and Associate Editor of Diabetes Care and Nephrology, Dialysis & Transplant.

Zielgruppe
Professional/practitioner
Leserkritik

From the reviews:

“This book discusses the epidemiology, pathophysiology, and medical management of kidney disease arising from heart failure. … designed to support the understanding and management of CKD in patients with heart failure, reviewing current practice in managing cardiorenal syndromes and concluding with advances in nephropathy management in patients … . Written by respected cardiologists and nephrologists, the book is intended for clinicians in both areas. … a well-written book that will prove useful in an academic healthcare setting or as continuing education for practice updates.” (Melissa K. Soper, Doody’s Review Service, January, 2013)

Publikation
Vereinigte Staaten
11.07.2012
speech-bubble-svg
Sprache
Englisch
book-svg Format
Hardcover
250 Seiten
package-svg Versand
Kostenloser Versand: Schweiz & Liechtenstein
Für den Versand nach Deutschland oder Frankreich werden die Versandgebühren der Schweizerischen Post berechnet. Diese werden Ihnen im Warenkorb für Ihre gesamte Bestellung berechnet.
subcategories-svg
Themen
Unterkategorie
Klinische & Innere Medizin
Zurück
Zum Start
S
SPIEGEL Bestseller
Hauptkategorie